Central-line associated bloodstream infection (CLABSI) is the costliest healthcare-associated infection, roughly $46,000 per instance, and can lead to prolonged hospital stays and mortality. However, most cases are preventable. Striving to diminish CLABSI, Oneida Healthcare created a task force to evaluate its processes related to central lines.
Using current evidence-based and best practice guidelines, Oneida Healthcare’s multidisciplinary task force conducted a complete review of patients with reported CLABSI and reviewed vascular access policies, procedures, practices and equipment. A vascular access audit tool was created and the infection prevention nurse, nurse educator and vascular access nurse initiated regular rounds on all applicable patients. They observed practices, corrected deficiencies and problem-solved at the bedside. The task force met bi-monthly to review audits and evaluate policies. They then reviewed and collated the information obtained from rounds and created a cause-and-effect document. This helped the team identify short- and long-term goals with respect to reaching a target of zero.
Since creation of the task force, central line insertion kits and standardized antiseptic have been instituted for all intravenous therapy. The intensive care unit has been without a CLABSI since 2008; the medical/surgical unit has been without CLABSI since 2012.
For more information, contact Jeanne T. Miller, RN, BSN, CIC, Manager, Infection Prevention/
Employee Health, Oneida Healthcare, at (315) 363-6000, ext. 1338 or at email@example.com.